Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Denekamp

Showing results (201-210 of 212) with videos related to

Pageof 22
Sort By:
Cancer Research|October 28, 1999
The ribonucleoside diphosphate reductase inhibitor (E)-2'-deoxy-(fluoromethylene)cytidine as a cytotoxic radiosensitizer in vitroP A Coucke, L A Decosterd, Y X Li, et al.
Radiation Research. Supplement|January 1, 1985
In vitro and in vivo studies of the TRIUMF pion therapy beamL D Skarsgard, B G Douglas, J Denekamp, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 9, 2000
ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative group of radiotherapy of the european organization for research and treatment of cancer (EORTC)J Bernier, J Denekamp, A Rojas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 1995
EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scaleJ J Pavy, J Denekamp, J Letschert, et al.
International Journal of Radiation Oncology, Biology, Physics|March 30, 1995
EORTC Late Effects Working Group. Late Effects toxicity scoring: the SOMA scaleJ J Pavy, J Denekamp, J Letschert, et al.
Frontiers of Radiation Therapy and Oncology|January 1, 1988
Radiotherapy with three fractions per day for twelve consecutive days for tumors of the thorax, head and neckM I Saunders, S Dische, J F Fowler, et al.
British Journal of Cancer|June 9, 1999
Evidence for characteristic vascular patterns in solid tumours: quantitative studies using corrosion castsM A Konerding, W Malkusch, B Klapthor, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Radiotherapy employing three fractions on each of twelve consecutive daysM I Saunders, S Dische, J F Fowler, et al.
Cancer Research|January 1, 1995
Combined radioimmunotherapy and radiotherapy of human colon carcinoma grafted in nude miceF Buchegger, A Rojas, A B Delaloye, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 30, 1999
ARCON: accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: a phase I/II study by the EORTCJ Bernier, J Denekamp, A Rojas, et al.
Pageof 22

Showing results (201-210 of 212) with videos related to

Sort By:
Pageof 22
Cancer Research|October 28, 1999
The ribonucleoside diphosphate reductase inhibitor (E)-2'-deoxy-(fluoromethylene)cytidine as a cytotoxic radiosensitizer in vitroP A Coucke, L A Decosterd, Y X Li, et al.
Radiation Research. Supplement|January 1, 1985
In vitro and in vivo studies of the TRIUMF pion therapy beamL D Skarsgard, B G Douglas, J Denekamp, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 9, 2000
ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative group of radiotherapy of the european organization for research and treatment of cancer (EORTC)J Bernier, J Denekamp, A Rojas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 1995
EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scaleJ J Pavy, J Denekamp, J Letschert, et al.
International Journal of Radiation Oncology, Biology, Physics|March 30, 1995
EORTC Late Effects Working Group. Late Effects toxicity scoring: the SOMA scaleJ J Pavy, J Denekamp, J Letschert, et al.
Frontiers of Radiation Therapy and Oncology|January 1, 1988
Radiotherapy with three fractions per day for twelve consecutive days for tumors of the thorax, head and neckM I Saunders, S Dische, J F Fowler, et al.
British Journal of Cancer|June 9, 1999
Evidence for characteristic vascular patterns in solid tumours: quantitative studies using corrosion castsM A Konerding, W Malkusch, B Klapthor, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Radiotherapy employing three fractions on each of twelve consecutive daysM I Saunders, S Dische, J F Fowler, et al.
Cancer Research|January 1, 1995
Combined radioimmunotherapy and radiotherapy of human colon carcinoma grafted in nude miceF Buchegger, A Rojas, A B Delaloye, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 30, 1999
ARCON: accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: a phase I/II study by the EORTCJ Bernier, J Denekamp, A Rojas, et al.
Pageof 22